Xeris Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Adcock Ingram Holdings ZAR 997.56M 6.08M 2024-06
Celltrion KRW 239.71B 17.94B 2024-09
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.54M 530K 2024-09
Ecofibre AUD 8.03M 1.38M 2024-06
Eli Lilly USD 2.42B 324.7M 2024-12
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pharma Mar EUR 13.23M 2.55M 2024-12
Qiagen NV USD 141.71M 1.05M 2024-12
Sartorius EUR 216.7M 8.5M 2024-09
Sino Biopharmaceutical CNY 3.42B 1.2B 2024-06
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 168.44M 20.66M 2024-09



Xeris Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.